«Health» organizes a training course on applying artificial intelligence solutions to support medical decision-making in breast cancer treatment...
«Health» organizes a training course on applying artificial intelligence solutions to support medical decision-making in breast cancer treatment
The Ministry of Health and Population organized a training course on applying artificial intelligence solutions to support medical decision-making in breast cancer treatment, in cooperation with the global companies AstraZeneca and Clinithink, as part of strengthening the Presidential Initiative for Women's Health Support.
The training course aims to employ artificial intelligence technologies to analyze medical records with high accuracy, and to train doctors to use these tools to speed up screening, diagnosis and the start of treatment, thereby enhancing the efficiency of health services.
Dr. Hossam Abdel Ghaffar, Official Spokesperson of the Ministry of Health and Population, stressed that this training course is a step towards mainstreaming artificial intelligence in health initiatives to reduce diagnosis time and improve services, especially in the field of oncology.
Dr. Mohamed Hassany, Assistant Minister of Health for Public Health Projects and Initiatives, pointed out that this partnership supports building an integrated digital health system, in line with «Egypt 2030» Vision, through electronic health records and artificial intelligence technologies.
He explained that the Presidential Initiative for Women's Health Support has received 60.8 million visits since its launch in July 2019, stressing that the use of artificial intelligence represents a qualitative shift in early detection, raising the efficiency of treatment and improving the chances of recovery through the application of Digital Pathology technologies in cooperation with AstraZeneca.
Major General Dr. Amr Ayed, Assistant Minister of Health and Population for Digital Transformation, stressed the importance of harnessing artificial intelligence to serve patients at all stages of screening, diagnosis and treatment.
Dr. Maha Ibrahim, Head of the General Secretariat of Specialized Medical Councils, affirmed that this training course enhances the quality of health services and supports digital transformation and the Sustainable Development Goals.
Dr. Ahmed Koshta, Head of Corporate Affairs at AstraZeneca Egypt, explained that Clinithink technologies enable accurate analysis of electronic medical records, helping to identify high-risk cases and enhance the accuracy of medical decisions.
A select group of experts took part in the course, including Dr. Hatem Amin, Executive Director of the Presidential Initiative for Women's Health, Dr. Khaled Abdel Aziz, Executive Director of the Initiative for Early Detection of Tumors, Dr. Emad Shash, Professor of Oncology at Cairo University, Dr. Ahmed Hassan Abdel Aziz, Professor of Oncology at Ain Shams University, Dr. Mona Khalifa, Director General of the General Administration of Initiatives, and Dr. Heba Azzam, Professor of Diagnostic Radiology at Cairo University.